Factors Influencing Buprenorphine Prescribing among Physicians in New York State

Table 1

Characteristics of buprenorphine prescribers versus nonprescribers.

Characteristics	Total n (%) or mean (SD) n = 91	Current prescribers n (%) or mean (SD) n = 60	Nonprescribers n (%) or mean (SD) n = 31	OR (95% CI)	value
Age	52 (12.8); N = 83	53.9 (13.3); N = 55	48.1 (11.1); N = 28	1.04 (0.99–1.08)	0.055
Gender
Male	64 (70.3)	42 (70.0)	22 (71.0)	Reference
Female	27 (29.7)	18 (30.0)	9 (29.0)	1.05 (0.40–2.71)	0.924
Race/ethnicity
White	66 (70.3)	48 (80.0)	18 (58.1)	Reference
Non-white	25 (27.5)	12 (20.0)	13 (41.9)	0.35 (0.13–0.90)	0.029
Geographic location
New York City	52 (57.1)	33 (55.0)	19 (61.3)	Reference
Outside New York City	39 (42.9)	27 (44.5)	12 (38.7)	1.30 (0.54–3.14)	0.566
Years in practice	19 (13); N = 85	21.6 (13.7); N = 55	14.5 (10.3); N = 30	1.05 (1.01–1.10)	0.022
Primary practice specialty
Psychiatry	44 (48.4)	25 (41.7)	18 (58.1)	Reference
Medicine	35 (38.5)	28 (46.7)	8 (25.8)	2.52 (0.93–6.80)	0.068
Other	12 (13.2)	7 (11.7)	5 (16.1)	1.01 (0.28–3.69)	0.990
Addiction specialty
Addiction specialist	17 (18.7)	15 (25.0)	2 (6.5)	Reference
Nonaddiction specialist	74 (81.3)	45 (75.0)	29 (93.5)	0.21 (0.04–0.97)	0.046
Primary practice type
Solo practice	30 (33.0)	25 (41.7)	5 (16.1)	Reference
Group practice	61 (67.0)	35 (58.3)	26 (83.9)	0.27 (0.09–0.80)	0.018
Academic affiliation
Yes	51 (56.7)	29 (48.3)	22 (73.3)	Reference
No	39 (43.3); N = 90	31 (51.7); N = 60	8 (26.7); N = 30	2.94 (1.13–7.64)	0.027
Buprenorphine effectiveness
Heavy/moderate	82 (90.1)	55 (93.2)	27 (93.1)	Reference
Limited/none/DK	6 (6.6); N = 88	4 (6.8); N = 59	2 (6.9); N = 29	0.98 (0.17–5.70)	0.984
How many other buprenorphine providers do you know?	7.03 (8.5); N = 79	8.60 (10.0); N = 52	4.0 (2.8); N = 27	1.19 (1.03–1.38)	0.020

DK: do not know.